| PUBCHEM ID |
76685216
|
| UNII |
FWL2263R77
|
| Preferred Term |
ZOLIFLODACIN
|
| CAS |
1620458-09-4
|
| INCHIKEY |
ZSWMIFNWDQEXDT-ZESJGQACSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C[C@H](CO1)N(c2noc3c2cc(CC([C@H]2N4C[C@H](C)O[C@@H]2C)(C(NC(N2)=O)=O)C2=O)c4c3F)C1=O
|
| Total Surface Area |
321,65
|
| Relative PSA |
0,39565
|
| TPSA |
143,31
|
| cLogS |
-5,859
|
| MW |
487,443
|
| cLogP |
0,5208
|
| H-Acceptors |
12
|
| H-Donors |
2
|
| Ro5 violations |
1
|
| Druglikeness |
4,1436
|
| DrugScore |
0,177158695551476
|
| Mutagenic |
high
|
| Tumorigenic |
none
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,8023
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,3052
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,608
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6408
|
| Carcinogenicity (Three-class) |
Non-required
|
